Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AMG 650 |
| Synonyms | |
| Therapy Description |
AMG 650 inhibits the kinesin motor protein KIF18A, potentially resulting in decreased tumor growth (J Clin Oncol 39, 2021 (suppl 15; abstr TPS5600), Cancer Res (2023) 83 (7_Supplement): 516). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AMG 650 | AMG-650|AMG650|Sovilnesib | AMG 650 inhibits the kinesin motor protein KIF18A, potentially resulting in decreased tumor growth (J Clin Oncol 39, 2021 (suppl 15; abstr TPS5600), Cancer Res (2023) 83 (7_Supplement): 516). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04293094 | Phase I | AMG 650 | Study of AMG 650 in Adult Participants With Advanced Solid Tumors | Completed | USA | ITA | ESP | CAN | BEL | AUS | 1 |
| NCT06084416 | Phase I | AMG 650 | A Study of Sovilnesib in Subjects With Ovarian Cancer | Active, not recruiting | USA | 0 |